ADAM6 and acute leukemia: In the whole study cohort, including control subjects and acute leukemia patients, Serum levels of ADAM6 were found to be significantly negatively correlated with serum levels of PRSS1 (r = −0.4264, p < 0.0001, Fig. 4D).